We recently reported that mitogen-activated protein kinase (MAPK) JNK1 interacts with and negatively regulates β-catenin signaling through GSK3β [2], and that the β-catenin alteration is likely to be associated with intestinal tumor formation induced by JNK1 inactivation [2]. The gene discussed is MAPK8; the disease is intestinal neoplasm.